About Our Program

As a research center embedded within Kaiser Permanente’s large and dynamic health care system, our investigators have a unique opportunity to apply scientific expertise to real-world clinical problems, translate findings into practice, and share what we learn with the broader community.

Featured Scientist

Amandeep Sahota, MD
Principal Investigator
Los Angeles
Hepatology
Clinical.Trials@kp.org

Dr. Amandeep Sahota is physician in charge for the Department of Hepatology at the Kaiser Permanente Los Angeles Medical Center. She is also assistant medical director of Transplant Services for Kaiser Permanente Southern California. In this role, she promotes clinical quality programs, implementation of virtual medicine, and data analytics on chronic diseases outcomes. Her efforts have improved patient access to care, advanced screening for advanced liver disease, and innovated care delivery ...

Featured Video

Research showing value of exercise before COVID-19 diagnosis earns special recognition

Being active can lower your risk of getting seriously ill with COVID, regardless of your race or the chronic conditions you may have, according to research published last year in the American Journal of Preventive Medicine.

The Kaiser Permanente Southern California findings were important, impactful, and influential. As a result, the journal editors chose the research article, “Associations of Physical Inactivity and COVID-19 Outcomes Among Subgroups,” as the American Journal of Preventive Medicine 2023 Article of the Year.

News

Featured Image of News Story Titled: COVID-19 vaccination not linked to tinnitus

COVID-19 vaccination not linked to tinnitus

New Kaiser Permanente research shows that the COVID-19 vaccine does not increase the risk of developing tinnitus, which is a ringing in the ears. “Early on in the COVID-19 pandemic, some people complained about hearing some sound after being vaccinated, but it wasn’t actually an external sound, it was tinnitus, which is the perception of ...

Fewer breast cancer patients received imaging follow-up after COVID-19 hit

A new Kaiser Permanente study showed that fewer breast cancer survivors received recommended annual breast cancer imaging in the time after the COVID-19 pandemic period compared to before the pandemic. The study was published in JAMA Oncology in July 2025. Little has been known previously about the impact of the COVID-19 pandemic on post-treatment surveillance ...

Finding factors that could help patients achieve remission from Type 2 diabetes

A diagnosis of Type 2 diabetes typically means a future of blood sugar monitoring and glucose-lowering medications. But interest is growing in identifying which people with diabetes might be able to stop taking their medications and control their disease with diet and exercise alone. A new Kaiser Permanente study, published in Diabetes Care, sheds light ...

Comorbidities could increase risk of other cancers for breast cancer survivors

Kaiser Permanente research found that breast cancer survivors have a higher risk of developing other cancers if they have other preexisting health conditions, such as high blood pressure and diabetes. “Preexisting health conditions are common in people diagnosed with cancer and what we’ve learned with this study is that comorbidities — experiencing multiple illnesses or ...

Five questions for Dr. Maheen Humayun

Maheen Humayun, PhD, MPH, is an infectious disease epidemiologist and postdoctoral research fellow in the Department of Research & Evaluation. Prior to joining Kaiser Permanente, Dr. Humayun worked as an HIV Cluster Detection and Response Fellow at the Centers for Disease Control and Prevention. In that role, she analyzed national HIV surveillance data to detect rapid ...

Events

Featured Division

Epidemiologic Research

Our epidemiologists seek answers to important health questions with real-world clinical relevance.

Investigators with the Division of Epidemiologic Research apply rigorous research methods to address important health questions that have the potential to change clinical practice and health care delivery. The division’s research portfolio spans the care continuum, from etiology and prevention to survivorship and quality of life.

Division investigators have expertise in traditional epidemiologic studies, post-marketing safety and effectiveness studies, and outcomes research. Current research areas include cancer, cardiovascular disease, COVID-19, diabetes, infectious disease, molecular epidemiology, orthopedics and bone health, perinatal health, pharmacoepidemiology, and vaccines.